The Experts below are selected from a list of 22203 Experts worldwide ranked by ideXlab platform
Tatsushi Shingai - One of the best experts on this subject based on the ideXlab platform.
-
Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment.
American journal of surgery, 2007Co-Authors: Masataka Ikeda, Mitsugu Sekimoto, Shuji Takiguchi, Masayoshi Yasui, Katsuki Danno, Yujiro Fujie, Kotaro Kitani, Yosuke Seki, Taishi Hata, Tatsushi ShingaiAbstract:Abstract Background Portal or splenic vein thrombosis (PSVT) is a common disorder after laparoscopic splenectomy (LS). Splenomegaly is a well-known risk factor for PSVT. However, no treatment strategy for PSVT has been established. Methods Thirty-three consecutive patients who had undergone LS and postoperative imaging surveillance were examined. PSVT was classified according to the site of thrombosis. We evaluated patient background, operative factors, and clinical symptoms. Results Spleen Weight of patients with PSVT (n = 17, median 218 g) was greater than that of patients without PSVT (n = 16, median 101 g). Seven patients developed thrombosis involving the entire splenic vein (total splenic vein thrombosis), and 4 of them had clinical symptoms (fever >38°C and/or abdominal pain). The incidence of clinical symptoms was significantly more frequent in patients with than without total SVT. Operation time, blood loss, and Spleen Weight were also significantly greater in patients with total SVT. Multiple logistic regression analysis demonstrated Spleen Weight was the strongest predictor of PSVT and total SVT. Conclusion Patients with total SVT have greater risk factors for PSVT and frequently have clinical symptoms. They are candidates for anticoagulation therapy.
Masataka Ikeda - One of the best experts on this subject based on the ideXlab platform.
-
Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment.
American journal of surgery, 2007Co-Authors: Masataka Ikeda, Mitsugu Sekimoto, Shuji Takiguchi, Masayoshi Yasui, Katsuki Danno, Yujiro Fujie, Kotaro Kitani, Yosuke Seki, Taishi Hata, Tatsushi ShingaiAbstract:Abstract Background Portal or splenic vein thrombosis (PSVT) is a common disorder after laparoscopic splenectomy (LS). Splenomegaly is a well-known risk factor for PSVT. However, no treatment strategy for PSVT has been established. Methods Thirty-three consecutive patients who had undergone LS and postoperative imaging surveillance were examined. PSVT was classified according to the site of thrombosis. We evaluated patient background, operative factors, and clinical symptoms. Results Spleen Weight of patients with PSVT (n = 17, median 218 g) was greater than that of patients without PSVT (n = 16, median 101 g). Seven patients developed thrombosis involving the entire splenic vein (total splenic vein thrombosis), and 4 of them had clinical symptoms (fever >38°C and/or abdominal pain). The incidence of clinical symptoms was significantly more frequent in patients with than without total SVT. Operation time, blood loss, and Spleen Weight were also significantly greater in patients with total SVT. Multiple logistic regression analysis demonstrated Spleen Weight was the strongest predictor of PSVT and total SVT. Conclusion Patients with total SVT have greater risk factors for PSVT and frequently have clinical symptoms. They are candidates for anticoagulation therapy.
Shuji Takiguchi - One of the best experts on this subject based on the ideXlab platform.
-
Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment.
American journal of surgery, 2007Co-Authors: Masataka Ikeda, Mitsugu Sekimoto, Shuji Takiguchi, Masayoshi Yasui, Katsuki Danno, Yujiro Fujie, Kotaro Kitani, Yosuke Seki, Taishi Hata, Tatsushi ShingaiAbstract:Abstract Background Portal or splenic vein thrombosis (PSVT) is a common disorder after laparoscopic splenectomy (LS). Splenomegaly is a well-known risk factor for PSVT. However, no treatment strategy for PSVT has been established. Methods Thirty-three consecutive patients who had undergone LS and postoperative imaging surveillance were examined. PSVT was classified according to the site of thrombosis. We evaluated patient background, operative factors, and clinical symptoms. Results Spleen Weight of patients with PSVT (n = 17, median 218 g) was greater than that of patients without PSVT (n = 16, median 101 g). Seven patients developed thrombosis involving the entire splenic vein (total splenic vein thrombosis), and 4 of them had clinical symptoms (fever >38°C and/or abdominal pain). The incidence of clinical symptoms was significantly more frequent in patients with than without total SVT. Operation time, blood loss, and Spleen Weight were also significantly greater in patients with total SVT. Multiple logistic regression analysis demonstrated Spleen Weight was the strongest predictor of PSVT and total SVT. Conclusion Patients with total SVT have greater risk factors for PSVT and frequently have clinical symptoms. They are candidates for anticoagulation therapy.
Yosuke Seki - One of the best experts on this subject based on the ideXlab platform.
-
Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment.
American journal of surgery, 2007Co-Authors: Masataka Ikeda, Mitsugu Sekimoto, Shuji Takiguchi, Masayoshi Yasui, Katsuki Danno, Yujiro Fujie, Kotaro Kitani, Yosuke Seki, Taishi Hata, Tatsushi ShingaiAbstract:Abstract Background Portal or splenic vein thrombosis (PSVT) is a common disorder after laparoscopic splenectomy (LS). Splenomegaly is a well-known risk factor for PSVT. However, no treatment strategy for PSVT has been established. Methods Thirty-three consecutive patients who had undergone LS and postoperative imaging surveillance were examined. PSVT was classified according to the site of thrombosis. We evaluated patient background, operative factors, and clinical symptoms. Results Spleen Weight of patients with PSVT (n = 17, median 218 g) was greater than that of patients without PSVT (n = 16, median 101 g). Seven patients developed thrombosis involving the entire splenic vein (total splenic vein thrombosis), and 4 of them had clinical symptoms (fever >38°C and/or abdominal pain). The incidence of clinical symptoms was significantly more frequent in patients with than without total SVT. Operation time, blood loss, and Spleen Weight were also significantly greater in patients with total SVT. Multiple logistic regression analysis demonstrated Spleen Weight was the strongest predictor of PSVT and total SVT. Conclusion Patients with total SVT have greater risk factors for PSVT and frequently have clinical symptoms. They are candidates for anticoagulation therapy.
Mitsugu Sekimoto - One of the best experts on this subject based on the ideXlab platform.
-
Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment.
American journal of surgery, 2007Co-Authors: Masataka Ikeda, Mitsugu Sekimoto, Shuji Takiguchi, Masayoshi Yasui, Katsuki Danno, Yujiro Fujie, Kotaro Kitani, Yosuke Seki, Taishi Hata, Tatsushi ShingaiAbstract:Abstract Background Portal or splenic vein thrombosis (PSVT) is a common disorder after laparoscopic splenectomy (LS). Splenomegaly is a well-known risk factor for PSVT. However, no treatment strategy for PSVT has been established. Methods Thirty-three consecutive patients who had undergone LS and postoperative imaging surveillance were examined. PSVT was classified according to the site of thrombosis. We evaluated patient background, operative factors, and clinical symptoms. Results Spleen Weight of patients with PSVT (n = 17, median 218 g) was greater than that of patients without PSVT (n = 16, median 101 g). Seven patients developed thrombosis involving the entire splenic vein (total splenic vein thrombosis), and 4 of them had clinical symptoms (fever >38°C and/or abdominal pain). The incidence of clinical symptoms was significantly more frequent in patients with than without total SVT. Operation time, blood loss, and Spleen Weight were also significantly greater in patients with total SVT. Multiple logistic regression analysis demonstrated Spleen Weight was the strongest predictor of PSVT and total SVT. Conclusion Patients with total SVT have greater risk factors for PSVT and frequently have clinical symptoms. They are candidates for anticoagulation therapy.